Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 925 of 1,261
  1. US 2012100164

    SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIAL

    BRIMNES JENS [DK] · Granted Apr 26, 2012 · Expires Apr 21, 2032

    granted
  2. US 2012100163

    SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGEN

    BRIMNES JENS [DK] · Granted Apr 26, 2012 · Expires Apr 21, 2032

    granted
  3. US 8163935

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  4. US 8163732

    Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  5. US 8163545

    Vaccine against pandemic strains of influenza viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  6. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  7. US 8163294

    Growth regulatable recombinant BCG compositions

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  8. US 8163881

    Immunoglobulin molecules with improved characteristics

    The Board of Regents of the University of Texas System · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  9. US 8163782

    1,2,4-oxadiazole benzoic acid compositions

    PTC THERAPEUTICS, INC. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  10. US 8163772

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  11. US 8163309

    Starch foam microparticles

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  12. US 8163281

    Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  13. US 8163520

    Nucleic acids encoding a chimeric polypeptide comprising IL-7 and HGF-beta chain and methods of use

    UNIVERSITY OF CONNECTICUT · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  14. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  15. US 8163297

    Live attenuated aldolase-negative bacterial vaccine

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  16. US 8162918

    Gels with predetermined conductivity used in electroporation of tissue

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  17. US 8163779

    Glucokinase activators

    Takeda San Diego, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  18. US 8165643

    Charging cradle

    CHENG UEI PRECISION INDUSTRY CO., LTD. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  19. US 8163960

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  20. US 8163953

    Compounds for lysosomal modulation and methods of use

    UNIVERSITY OF CONNECTICUT · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  21. US 8163902

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  22. US 8163920

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  23. US 8163805

    Small molecule antagonists of Bcl-2 family proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  24. US 8163893

    Pseudotyped retroviral vectors and methods of use thereof

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.